company background image
STVN logo

Stevanato Group NYSE:STVN Stock Report

Last Price

US$19.32

Market Cap

US$5.5b

7D

-6.7%

1Y

-36.9%

Updated

20 Aug, 2024

Data

Company Financials +

STVN Stock Overview

Engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

STVN fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance1/6
Financial Health5/6
Dividends0/6

Stevanato Group S.p.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Stevanato Group
Historical stock prices
Current Share PriceUS$19.32
52 Week HighUS$35.56
52 Week LowUS$16.56
Beta0.58
11 Month Change-9.64%
3 Month Change-0.36%
1 Year Change-36.92%
33 Year Change-24.59%
5 Year Changen/a
Change since IPO-1.78%

Recent News & Updates

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?

Aug 21
Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?

Stevanato Group S.p.A. (NYSE:STVN) Looks Just Right With A 28% Price Jump

Jul 25
Stevanato Group S.p.A. (NYSE:STVN) Looks Just Right With A 28% Price Jump

Recent updates

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?

Aug 21
Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$19.3 Based On Its Intrinsic Value?

Stevanato Group S.p.A. (NYSE:STVN) Looks Just Right With A 28% Price Jump

Jul 25
Stevanato Group S.p.A. (NYSE:STVN) Looks Just Right With A 28% Price Jump

Does Stevanato Group (NYSE:STVN) Have A Healthy Balance Sheet?

Jul 23
Does Stevanato Group (NYSE:STVN) Have A Healthy Balance Sheet?

Stevanato: Destock Pressures, Long-Term Upside

May 29

Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 12
Stevanato Group S.p.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Stevanato Group S.p.A.'s (NYSE:STVN) Share Price Matching Investor Opinion

May 07
Stevanato Group S.p.A.'s (NYSE:STVN) Share Price Matching Investor Opinion

Stevanato Group's (NYSE:STVN) Solid Earnings May Rest On Weak Foundations

Mar 15
Stevanato Group's (NYSE:STVN) Solid Earnings May Rest On Weak Foundations

Stevanato: Destocking And Valuation Risk (Rating Downgrade)

Mar 12

Is Stevanato Group S.p.A. (NYSE:STVN) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 09
Is Stevanato Group S.p.A. (NYSE:STVN) Expensive For A Reason? A Look At Its Intrinsic Value

Stevanato: Guidance Reiterated And Supportive Revenue Growth

Nov 22

Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$31.6 Based On Its Intrinsic Value?

Oct 22
Is Stevanato Group S.p.A. (NYSE:STVN) Worth US$31.6 Based On Its Intrinsic Value?

Stevanato: Secular Tailwinds In Biologics Support Downstream Demand

Sep 15

Stevanato Group: Undeniable Quality, But Lacking Upside

Jun 14

Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Mar 05
Stevanato Group S.p.A. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next

Stevanato Group and Transcoject to provide pre-fillable syringe polymer options for pharma

Jan 24

There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price

Dec 28
There's Reason For Concern Over Stevanato Group S.p.A.'s (NYSE:STVN) Price

Stevanato Group Non-GAAP EPS of $0.14 beats by $0.01, revenue of $245.3M in-line

Nov 08

An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued

Aug 01
An Intrinsic Calculation For Stevanato Group S.p.A. (NYSE:STVN) Suggests It's 49% Undervalued

A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)

Apr 19
A Look At The Intrinsic Value Of Stevanato Group S.p.A. (NYSE:STVN)

Shareholder Returns

STVNUS Life SciencesUS Market
7D-6.7%1.8%3.1%
1Y-36.9%7.6%25.4%

Return vs Industry: STVN underperformed the US Life Sciences industry which returned 7.1% over the past year.

Return vs Market: STVN underperformed the US Market which returned 25.6% over the past year.

Price Volatility

Is STVN's price volatile compared to industry and market?
STVN volatility
STVN Average Weekly Movement7.1%
Life Sciences Industry Average Movement8.6%
Market Average Movement6.3%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.2%

Stable Share Price: STVN has not had significant price volatility in the past 3 months.

Volatility Over Time: STVN's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19495,635Franco Stevanatowww.stevanatogroup.com

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

Stevanato Group S.p.A. Fundamentals Summary

How do Stevanato Group's earnings and revenue compare to its market cap?
STVN fundamental statistics
Market capUS$5.46b
Earnings (TTM)US$136.36m
Revenue (TTM)US$1.21b

38.7x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
STVN income statement (TTM)
Revenue€1.09b
Cost of Revenue€773.78m
Gross Profit€313.85m
Other Expenses€191.29m
Earnings€122.56m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.45
Gross Margin28.86%
Net Profit Margin11.27%
Debt/Equity Ratio22.7%

How did STVN perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

12%

Payout Ratio